Re: Chimeric Antigen Receptor T Cells as Adjuvant Therapy for Unresectable Adenocarcinoma
Eur Urol
.
2024 Mar;85(3):304.
doi: 10.1016/j.eururo.2023.10.017.
Epub 2023 Nov 10.
Authors
Rodrigo España-Navarro
1
,
Karim Touijer
2
Affiliations
1
Department of Urology, Hospital Regional Universitario, University of Malaga, Málaga, Spain. Electronic address: espanarodrigo@outlook.com.
2
Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
PMID:
37951736
DOI:
10.1016/j.eururo.2023.10.017
No abstract available
MeSH terms
Adenocarcinoma* / therapy
Combined Modality Therapy
Humans
Receptors, Chimeric Antigen*
T-Lymphocytes
Substances
Receptors, Chimeric Antigen